Clinical Trial Detail

NCT ID NCT02085070
Title MK-3475 in Melanoma and NSCLC Patients With Brain Metastases
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Yale University
Indications

lung non-small cell carcinoma

Therapies

Pembrolizumab

Age Groups: adult

No variant requirements are available.